Journal - CNS & Neurological Disorders - Drug Targets

Impact Factor

Current: 4.388
5 - Year: 3.385

Ranking & Category

193rd of 261 in Neurosciences
166th of 261 in Pharmacology & Pharmacy

Topic(s) Covered

1 Topic(s)

View

Covered Disease(s)

1 Disease(s)

View

Aims & Scope

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes.

CNS & Neurological Disorders - Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of CNS & neurological drug targets. The journal also accepts for publication original research articles, letters, reviews and drug clinical trial studies.

As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

Abstracted/Indexed in

BIOSIS, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, British Library Cabell's Directory, Cambridge Scientific Abstracts (CSA)/ProQuest, Chemical Abstracts Service/SciFinder, ChemWeb, CNKI Scholar, Current Contents® - Clinical Medicine, Dimensions, EBSCO, EMBASE/Excerpta Medica, Genamics JournalSeek, Google Scholar, InCites, Index Copernicus, J-Gate, Journal Citation Reports/Science Edition, JournalTOCs, MediaFinder®-Standard Periodical Directory, MEDLINE/PubMed, Neuroscience Citation Index®, Open Abstracts (I4OA), Norwegian Register, PsycINFO, PubsHub, QOAM, Science Citation Index Expanded™ (SciSearch®), Scilit, Scopus, Suweco CZ, TOC Premier, and Ulrich's Periodicals Directory.

Journal History

Current Drug Targets - CNS & Neurological Disorders was launched in 2002 and later renamed in 2006 as CNS & Neurological Disorders - Drug Targets.

Abstracted/Indexed in

COPE COMPLIANT

Endorsement(s)

"This journal is the definitive source for the most meaningful and critical information available on CNS drug targets and progress both in industrial and academic based neurodegeneration research."

Rudolf E. Tanzi
Harvard Medical School, USA

Special Issue(s) - In-Press

Brain Imaging and Automatic Analysis in Neurological and Psychiatric diseases
Guest Editor(s): Yu-Dong Zhang, Ti-Fei Yuan, Zheng-Chao Dong
Tentative Publication Date: May, 2016
Submit Abstract via Email

Authors' Comments

I recommend CNS Neurological Disorders & Drug Targets to neuroscientists and practicing neurologists. The papers published on this platform are always of sufficient merit and quality. It maintains the highest standards of peer review, preserving the integrity of science.

Abdelrahman Ibrahim Abushouk
(Faculty of Medicine, Ain Shams University, Cairo, Egypt.)